• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

报告麻醉学中的利益冲突和指南赞助。一项横断面研究。

Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study.

机构信息

Division of Anaesthesiology, Geneva University Hospitals, Geneva, Switzerland.

Faculty of Medicine, University of Geneva, Geneva, Switzerland.

出版信息

PLoS One. 2019 Feb 27;14(2):e0212327. doi: 10.1371/journal.pone.0212327. eCollection 2019.

DOI:10.1371/journal.pone.0212327
PMID:30811517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6392260/
Abstract

Guideline recommendations may be biased due to conflicts of interest (COI) of panel members and sponsorship of the guideline. Potential impact of COI, and their management, should be transparently reported. We analysed 110 guidelines published in ten anaesthesia journals from 2007 to June 2018. We report on the number (%) that 1) published COI disclosures; 2) in a distinct paragraph; 3) described and explained the COI of panel members, and 4) of the Chairperson; 5) reported and described the presence or absence and potential impact of a sponsor of the guideline on the recommendations; and 6) reported how COI were managed. COI were published in 70/110 (64%) guidelines; in a distinct paragraph in 25/70 (36%). Panel members reported having no COI in 27/70 (39%) guidelines, disclosed COI without describing their potential impact in 41/70 (59%), and described their potential impact in 2/70 (3%). Chairpersons were identified in 50 guidelines, 32 of which published COI disclosures; 16/32 (50%) reported having no COI, 14/32 (44%) disclosed COI without describing their potential impact, 1/32 (3%) described their impact and 1/32 (3%) made no statement regarding COI. Presence or absence of a sponsor of the guideline was reported in 40 guidelines; 12/40 (30%) declared none, 24/40 (60%) reported sponsoring without explanation of the potential impact, and 4/40 (10%) described the potential influence of the sponsor on the guideline recommendations. Seventy-five guidelines reported COI of panel members and/or sponsorship of the guideline but only seven described how the COI had been managed. Disclosures of COI of panel members and of sponsors of guidelines have increased over the 12 year period, but remain insufficiently described and their potential influence on the guidelines' recommendations is poorly documented.

摘要

指南建议可能会因为小组成员的利益冲突(COI)和指南的赞助而存在偏差。应透明报告 COI 的潜在影响及其管理情况。我们分析了 2007 年至 2018 年 6 月在十本麻醉学期刊上发表的 110 项指南。我们报告了以下情况的指南数量(%):1)发表了 COI 披露信息;2)在单独的段落中;3)描述并解释了小组成员的 COI;4)主席的 COI;5)报告并描述了指南赞助商的存在、缺失及其对建议的潜在影响;6)报告了如何管理 COI。70/110(64%)项指南公布了 COI;25/70(36%)项指南在单独的段落中公布了 COI。70/110(39%)项指南的小组成员报告称不存在 COI,41/70(59%)项指南披露了 COI 但未描述其潜在影响,2/70(3%)项指南描述了其潜在影响。50 项指南中确定了主席的身份,其中 32 项公布了 COI 披露信息;16/32(50%)报告称不存在 COI,14/32(44%)披露了 COI 但未描述其潜在影响,1/32(3%)描述了其影响,1/32(3%)未就 COI 发表声明。40 项指南报告了指南的赞助商;12/40(30%)项指南未报告任何赞助商,24/40(60%)项指南报告了赞助但未解释潜在影响,4/40(10%)项指南描述了赞助商对指南建议的潜在影响。75 项指南报告了小组成员的 COI 和/或指南的赞助,但只有 7 项指南描述了如何管理 COI。小组成员和指南赞助商的 COI 披露信息在 12 年期间有所增加,但描述仍不充分,其对指南建议的潜在影响也记录不足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9005/6392260/8566e6ca30ed/pone.0212327.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9005/6392260/f280b47ad3a0/pone.0212327.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9005/6392260/8566e6ca30ed/pone.0212327.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9005/6392260/f280b47ad3a0/pone.0212327.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9005/6392260/8566e6ca30ed/pone.0212327.g002.jpg

相似文献

1
Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study.报告麻醉学中的利益冲突和指南赞助。一项横断面研究。
PLoS One. 2019 Feb 27;14(2):e0212327. doi: 10.1371/journal.pone.0212327. eCollection 2019.
2
Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study.考虑到智力,除了财务,利益冲突在临床实践指南中被证明是重要的:一项描述性研究。
J Clin Epidemiol. 2014 Nov;67(11):1222-8. doi: 10.1016/j.jclinepi.2014.05.006. Epub 2014 Jun 23.
3
Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.国家指南资料库中临床实践指南的利益冲突披露。
PLoS One. 2012;7(11):e47343. doi: 10.1371/journal.pone.0047343. Epub 2012 Nov 7.
4
Conflict of Interest in Seminal Hepatitis C Virus and Cholesterol Management Guidelines.在丙型肝炎病毒和胆固醇管理指南中的利益冲突。
JAMA Intern Med. 2017 Mar 1;177(3):352-357. doi: 10.1001/jamainternmed.2016.8439.
5
Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.加拿大和美国制作临床实践指南的专家组委员中存在财务利益冲突的比例:横断面研究。
BMJ. 2011 Oct 11;343:d5621. doi: 10.1136/bmj.d5621.
6
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study.2020 年美国临床实践指南医师作者的财务利益冲突:一项横断面研究。
BMJ Open. 2023 Jan 23;13(1):e069115. doi: 10.1136/bmjopen-2022-069115.
7
Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.临床实践指南中利益冲突报告不足:横断面研究。
BMC Med Ethics. 2013 May 3;14:19. doi: 10.1186/1472-6939-14-19.
8
Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians.披露临床指南和指导声明中的利益冲突及其管理:美国医师学院临床指南委员会的方法。
Ann Intern Med. 2019 Sep 3;171(5):354-361. doi: 10.7326/M18-3279. Epub 2019 Aug 20.
9
Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey.系统评价中卫生政策和体系研究的财务和非财务利益冲突报告:一项横断面调查。
Int J Health Policy Manag. 2018 Aug 1;7(8):711-717. doi: 10.15171/ijhpm.2017.146.
10
Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch.德国临床实践指南中财务利益冲突的管理:来自公共数据库GuidelineWatch的结果。
BMC Med Ethics. 2018 Jun 28;19(1):65. doi: 10.1186/s12910-018-0309-y.

本文引用的文献

1
Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications.高收益药物相关临床指南作者的财务利益冲突发生率。
JAMA Intern Med. 2018 Dec 1;178(12):1712-1715. doi: 10.1001/jamainternmed.2018.5106.
2
Conflicts of interest disclosure forms and management in critical care clinical practice guidelines.重症监护临床实践指南中的利益冲突披露表和管理。
Intensive Care Med. 2018 Oct;44(10):1691-1698. doi: 10.1007/s00134-018-5367-6. Epub 2018 Sep 27.
3
Time trends in the reporting of conflicts of interest, funding and affiliation with industry in intensive care research: a systematic review.
重症监护研究中利益冲突、资金和与行业关联的报告的时间趋势:系统评价。
Intensive Care Med. 2018 Oct;44(10):1669-1678. doi: 10.1007/s00134-018-5350-2. Epub 2018 Aug 23.
4
If the "Physician Payments Sunshine Act" Is a Solution, What Is the Problem?
Am J Bioeth. 2017 Jun;17(6):29-30. doi: 10.1080/15265161.2017.1313339.
5
Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry.临床实践指南作者的财务披露与行业报告之间的差异。
Medicine (Baltimore). 2017 Jan;96(2):e5711. doi: 10.1097/MD.0000000000005711.
6
Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.人工甜味饮料对体重影响的综述中研究结果与偏倚风险、研究资助及作者经济利益冲突之间的关系:一项综述的系统评价
PLoS One. 2016 Sep 8;11(9):e0162198. doi: 10.1371/journal.pone.0162198. eCollection 2016.
7
Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study.制定临床实践指南的组织与生物医学行业之间的财务关系:一项横断面研究。
PLoS Med. 2016 May 31;13(5):e1002029. doi: 10.1371/journal.pmed.1002029. eCollection 2016 May.
8
Nondisclosure of Financial Interest in Clinical Practice Guideline Development: An Intractable Problem?临床实践指南制定中财务利益的不披露:一个棘手的问题?
PLoS Med. 2016 May 31;13(5):e1002030. doi: 10.1371/journal.pmed.1002030. eCollection 2016 May.
9
Promoting Education Regarding Conflict of Interest Management.促进关于利益冲突管理的教育
J Korean Med Sci. 2016 Mar;31(3):473-4. doi: 10.3346/jkms.2016.31.3.473. Epub 2016 Feb 12.
10
How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors.系统评价的作者如何处理原始研究中的研究不当行为和 misconduct?对系统评价及其作者的横断面分析。 (注:这里“misconduct”常见释义为“不当行为”,但在医学语境中也可根据具体情况灵活处理,比如“行为不检点”等,此处保留英文以便更准确理解原文确切所指范围。)
BMJ Open. 2016 Mar 2;6(3):e010442. doi: 10.1136/bmjopen-2015-010442.